![These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S. These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=pradaxa-21.jpg&id=749356)
These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S.
![Blood & Clots Series: How do I determine if my patient on a DOAC is still at increased risk of bleeding? - CanadiEM Blood & Clots Series: How do I determine if my patient on a DOAC is still at increased risk of bleeding? - CanadiEM](https://canadiem.org/wp-content/uploads/2019/09/Blog-44-Finalized-1.png.webp)
Blood & Clots Series: How do I determine if my patient on a DOAC is still at increased risk of bleeding? - CanadiEM
![These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S. These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=pradaxa-22.jpg&id=749356)
These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S.
![No evidence to support routine blood monitoring for new oral anticoagulants - apixaban (Eliquis), dabigatran (Pradaxa) and rivaroxaban (Xarelto) | myVMC No evidence to support routine blood monitoring for new oral anticoagulants - apixaban (Eliquis), dabigatran (Pradaxa) and rivaroxaban (Xarelto) | myVMC](https://www.myvmc.com/wp-content/uploads/2014/10/spilled_pills_drugs_medication_medicine_595x240-595x240.jpg)